Fortified milk for pregnant and breastfeeding women to improve breast milk nutrients
Official title: Effect of Consumption of a Dairy Product Designed for Pregnant and Lactating Women on the Composition of Human Milk. A Quasi-experimental Study in a Vulnerable Population
Run by Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · NCT07173881 · Data updated 2026-11-12
This will test whether pregnant women who drink Super Mil Mamá, a fortified powdered milk, have higher levels of DHA and key vitamins and minerals in their breast milk at one month after delivery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri Academic / other |
| Locations | 2 sites (La Plata, Buenos Aires and 1 other locations) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | October 30, 2025 |
| Study ends | January 30, 2026 |
| Registry record updated | September 15, 2025 |
| Trial ID | NCT07173881 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women over 18 years old at about 28 weeks' gestation who regularly consume milk, receive care at the participating La Plata clinics, and plan to breastfeed.
✕Probably not a fit
Women with multiple pregnancies, malabsorption disorders, those who do not regularly consume milk, or those who do not breastfeed are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Pregnant women receiving prenatal care in La Plata are offered Super Mil Mamá (SMM), a whole milk powder fortified with multiple vitamins, minerals, and DHA, and their outcomes are compared with women who did not consume the product. The main outcome is the concentration of DHA, vitamins A, E, and D, iron, iodine, zinc, and calcium in human milk at one month postpartum, along with measures of maternal nutritional status. The intervention group is enrolled around 28±1 weeks' gestation and includes women who regularly consume milk; the comparison group includes mothers presenting for their infant's first-month checkup who exclusively breastfeed. Clinical data and milk samples are collected around delivery and at one month postpartum to compare nutrient levels between groups.
Why it matters
Potential benefit: If successful, the fortified milk could raise important nutrient levels in breast milk and support better infant growth and development in the first month of life.
How similar studies have gone: Previous maternal supplementation studies have shown that adding DHA and certain micronutrients can increase those nutrients in breast milk, but this specific fortified product has not been tested at the population level.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Intervention group: Pregnant women over 18 years of age who undergo prenatal care during gestational weeks (GW) 28 ± 1 at the Maternal Nutrition Clinic of the H.I.G.A. "San Martín" in La Plata, and who regularly consume milk, will be included. * Control group: Women over 18 years of age who attend their child's first checkup before the first month of life at the Maternal Clinic of the IDIP Health Observatory, and who exclusively breastfeed their children, will be included. Exclusion Criteria: * Women who have had multiple pregnancies and/or women with malabsorption diseases.
Where it's running
-
Hospital Interzonal de Agudos General San Martín
La Plata, Buenos Aires, Argentina Recruiting -
Instituto de Desarrollo e Investigaciones Pediátricas (IDIP) - HIAEP Sor María Ludovica
La Plata, Buenos Aires, Argentina Recruiting
Study contacts
- Study coordinator: Maria F Andreoli, PhD
- Email: mfandreoli@gmail.com
- Phone: 542214177324
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.